Caren Deardorf
About Caren Deardorf
Executive Vice President and Chief Commercial and Strategy Officer
Caren Deardorf holds the position of Executive Vice President and Chief Commercial and Strategy Officer. In this executive role, she is responsible for overseeing commercial strategies and initiatives, driving business growth, and aligning strategic objectives with overall corporate goals. Her extensive experience in various commercial roles has equipped her with the skills necessary to guide the company’s commercial operations effectively.
Caren Deardorf Education and Expertise
Caren Deardorf possesses a solid educational foundation with a Bachelor of Science degree in biology from Tufts University. Further enhancing her business acumen, she earned a Master of Business Administration from the Olin Graduate School of Business at Babson College. This combination of biological sciences and business management expertise underpins her strategic and commercial leadership in the biotechnology sector.
Former Chief Commercial Officer at Magenta Therapeutics
Caren Deardorf served as the Chief Commercial Officer at Magenta Therapeutics, a clinical-stage company. During her tenure, she focused on developing and implementing commercial strategies to position the company’s products successfully in the market. Her leadership contributed to guiding the organization through crucial stages of its growth and product development.
Caren Deardorf and Ohana Biosciences
At Ohana Biosciences, Caren Deardorf held the role of Chief Commercial Officer. She was responsible for crafting and executing the company’s commercial strategy, including comprehensive planning for the launch of its first product. Her work played a pivotal role in laying the groundwork for the company’s market entry and subsequent commercial success.
Commercial Roles at Biogen
While at Biogen, Caren Deardorf held several commercial roles, including Vice President, Product Development & Commercialization. She led the global launch of SPINRAZA, a significant treatment in the field of neuroscience. Additionally, she was instrumental in building Biogen’s multiple sclerosis franchise and establishing its global leadership through effective US and worldwide brand management.
Board Memberships and Non-profit Involvement
Caren Deardorf serves on the Board of Directors of both Crinetics Pharmaceuticals and NeuroSense Therapeutics, lending her expertise to guide these organizations. Outside of her professional career, she is an active cyclist and board member for the Pan-Mass Challenge. This non-profit organization is dedicated to raising funds for the Dana-Farber Cancer Institute, demonstrating her commitment to community and health-related causes.